Gefitinib Has the Potential of Activating Cell Immunity Against Malignant Cells
作者： Shigenori Kanazawa , Mikiko Muramatsu , Yoshimi Kinoshita , Kazuyuki Yamaguchi , Shosaku Nomura
关键词:
摘要:
jco.org参考文章(5)
A S Weyrich, M R Elstad, R P McEver, T M McIntyre, K L Moore, J H Morrissey, S M Prescott, G A Zimmerman, Activated platelets signal chemokine synthesis by human monocytes. Journal of Clinical Investigation. ,vol. 97, pp. 1525- 1534 ,(1996) , 10.1172/JCI118575
Isamu Okamoto, Kazuhiko Fujii, Mitsuhiro Matsumoto, Yasuhiro Terasaki, Nanae Kihara, Hirotsugu Kohrogi, Moritaka Suga, Diffuse alveolar damage after ZD1839 therapy in a patient with non-small cell lung cancer. Lung Cancer. ,vol. 40, pp. 339- 342 ,(2003) , 10.1016/S0169-5002(03)00043-6
Manuela Campiglio, Nicola Normanno, Massimo Di Maio, Francesco Perrone, Molecular markers to predict response to gefitinib: EGFR, ErbB-2, or more? Journal of Clinical Oncology. ,vol. 22, pp. 2035- 2036 ,(2004) , 10.1200/JCO.2004.99.337
Y Kameyoshi, A Dörschner, A I Mallet, E Christophers, J M Schröder, Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. Journal of Experimental Medicine. ,vol. 176, pp. 587- 592 ,(1992) , 10.1084/JEM.176.2.587
Federico Cappuzzo, Vanesa Gregorc, Elisa Rossi, Alessandra Cancellieri, Elisabetta Magrini, Carlo Terenzio Paties, Giovanni Ceresoli, Laura Lombardo, Stefania Bartolini, Cesare Calandri, Marisa De Rosa, Eugenio Villa, Lucio Crinò, Gefitinib in Pretreated Non–Small-Cell Lung Cancer (NSCLC): Analysis of Efficacy and Correlation With HER2 and Epidermal Growth Factor Receptor Expression in Locally Advanced or Metastatic NSCLC Journal of Clinical Oncology. ,vol. 21, pp. 2658- 2663 ,(2003) , 10.1200/JCO.2003.01.039